نتائج البحث - "Sunethra Wimalasundera"

1

دورية أكاديمية

Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial

المؤلفون: Navita L. Mallalieu, Sunethra Wimalasundera, Joy C. Hsu, Wendy Douglass, Chris Wells, Inmaculada Calvo Penades, Ruben Cuttica, Hans-Iko Huppertz, Rik Joos, Yukiko Kimura, Diana Milojevic, Margalit Rosenkranz, Kenneth Schikler, Tamas Constantin, Carine Wouters

المصدر: Pediatric Rheumatology Online Journal, Vol 17, Iss 1, Pp 1-10 (2019)

مصطلحات موضوعية: Biological therapy, Inflammation, Juvenile idiopathic arthritis, Pharmacokinetics, Pediatrics, RJ1-570, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12969-019-0364-z; https://doaj.org/toc/1546-0096

URL الوصول: https://doaj.org/article/7f02982439724267a0d9a1e6ca5fa34f

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

2

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

المصدر: Arthritis & Rheumatology (Hoboken, N.j.)

مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Adolescent, Immunology, Population, Full Length, Arthritis, Placebo, Antibodies, Monoclonal, Humanized, Infections, 03 medical and health sciences, Juvenile Arthritis Disease Activity Score, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Chickenpox, Rheumatology, 030225 pediatrics, Internal medicine, medicine, Immunology and Allergy, Humans, Patient Reported Outcome Measures, Adverse effect, education, skin and connective tissue diseases, Bronchitis, Child, Glucocorticoids, 030203 arthritis & rheumatology, education.field_of_study, business.industry, Cellulitis, Pneumonia, medicine.disease, Pediatric Rheumatology, Arthritis, Juvenile, Clinical trial, Methotrexate, Treatment Outcome, chemistry, Antirheumatic Agents, Child, Preschool, Female, Chemical and Drug Induced Liver Injury, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b134ea905446bbdd96810445ac41b0d6
http://europepmc.org/articles/PMC7986602

View record at Wiley

3

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis

المصدر: Rheumatology (Oxford, England)

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Adolescent, Injections, Subcutaneous, Arthritis, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Rheumatology, Pharmacokinetics, autoinflammatory conditions, Internal medicine, biologic therapies, Injection site, medicine, Juvenile, Humans, Pharmacology (medical), Dosing, Child, AcademicSubjects/MED00360, 030203 arthritis & rheumatology, Dose-Response Relationship, Drug, business.industry, Infant, Clinical Science, medicine.disease, Interim analysis, Arthritis, Juvenile, 030104 developmental biology, Treatment Outcome, chemistry, inflammation, Pharmacodynamics, Antirheumatic Agents, Child, Preschool, juvenile idiopathic arthritis, Female, cytokines and inflammatory mediators, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20149b973cfa7dd18ad97a9a635829fa
http://europepmc.org/articles/PMC8487273

4

Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial

المؤلفون: Ruben Cuttica, Rik Joos, Hans-Iko Huppertz, Chris Wells, Diana Milojevic, Joy C. Hsu, Kenneth N. Schikler, Tamás Constantin, Wendy Douglass, Sunethra Wimalasundera, Yukiko Kimura, Inmaculada Calvo Penades, Navita L. Mallalieu, Margalit Rosenkranz, Carine Wouters

المصدر: Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal, Vol 17, Iss 1, Pp 1-10 (2019)

مصطلحات موضوعية: Male, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Cmax, Phases of clinical research, Arthritis, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Drug Hypersensitivity, 03 medical and health sciences, Cmin, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Rheumatology, Internal medicine, Clinical endpoint, Immunology and Allergy, Medicine, Humans, Biological therapy, Pharmacokinetics, 030212 general & internal medicine, 030203 arthritis & rheumatology, Inflammation, business.industry, Incidence (epidemiology), lcsh:RJ1-570, Infant, lcsh:Pediatrics, Juvenile idiopathic arthritis, medicine.disease, Arthritis, Juvenile, Treatment Outcome, chemistry, Pharmacodynamics, Antirheumatic Agents, Pediatrics, Perinatology and Child Health, Female, lcsh:RC925-935, business, Research Article

وصف الملف: Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9ab131b2a064fbb539cdacd8c6a956a
https://pubmed.ncbi.nlm.nih.gov/31438986

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

5

170 Safety and efficacy of subcutaneous tocilizumab in patients with systemic and polyarticular juvenile idiopathic arthritis

المؤلفون: Navita L. Mallalieu, Kirsten Minden, Ruben Cuttica, Alberto Martini, N Ruperto, Hermine I. Brunner, Jennifer E. Weiss, Gerd Horneff, Markus Hufnagel, Fabrizio De Benedetti, Wendy Douglass, Daniel J. Lovell, Chris Wells, Sunethra Wimalasundera, Jordi Anton, Heinrike Schmeling, Athimalaipet V Ramanan, María Luz Gámir-Gámir, Michael Henrickson

المصدر: Rheumatology. 58

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Arthritis, medicine.disease, chemistry.chemical_compound, Tocilizumab, Rheumatology, chemistry, Internal medicine, Medicine, Juvenile, Pharmacology (medical), In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c5a1d1d07d863a1319d30a9d81a4fa5d
https://doi.org/10.1093/rheumatology/kez108.078

6

Additional file 1: of Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial

المؤلفون: Navita Mallalieu, Sunethra Wimalasundera, Hsu, Joy, Douglass, Wendy, Wells, Chris, Penades, Inmaculada, Cuttica, Ruben, Hans-Iko Huppertz, Joos, Rik, Kimura, Yukiko, Milojevic, Diana, Rosenkranz, Margalit, Schikler, Kenneth, Constantin, Tamas, Wouters, Carine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c49e15148a9502ea267a1f7a8b1b51e

7

THU0598 Safety of tocilizumab in patients aged <2 years with active systemic juvenile idiopathic arthritis treated for one year

المؤلفون: Margalit Rosenkranz, Carine Wouters, Hans Iko Huppertz, Sunethra Wimalasundera, Ruben Cuttica, Yukiko Kimura, I. Calvo Penadés, Tamás Constantin, Rik Joos, Wendy Douglass, Chris Wells, D. Milojevic, Kenneth N. Schikler

المصدر: THURSDAY, 14 JUNE 2018.

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Phases of clinical research, Arthritis, Neutropenia, medicine.disease, Rash, chemistry.chemical_compound, Tocilizumab, Upper respiratory tract infection, chemistry, Pharmacokinetics, Internal medicine, medicine, Vomiting, medicine.symptom, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7446aeb837630834a260412952e54339
https://doi.org/10.1136/annrheumdis-2018-eular.2628

8

06. Identification of optimal subcutaneous doses of tocilizumab in children with polyarticular-course juvenile idiopathic arthritis

المؤلفون: Fabrizio De Benedetti, AK Kadva, Kamal N. Bharucha, Sunethra Wimalasundera, Navita L. Mallalieu, Hermine I. Brunner, J Weiss, Kirsten Minden, Nicolino Ruperto, Ruchi Upmanyu, Michael Henrickson, Jordi Anton, Heinrike Schmeling, Ruben Cuttica, Athimalaipet V Ramanan, Alberto Martini, Daniel J. Lovell, Shazad Jafri, Joy C. Hsu

المصدر: Rheumatology. 56

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Arthritis, medicine.disease, chemistry.chemical_compound, Tocilizumab, Rheumatology, chemistry, Internal medicine, medicine, Juvenile, Pharmacology (medical), Identification (biology), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b2c60157a42608e1ce0c29d87e996888
https://doi.org/10.1093/rheumatology/kex356.052

9

OP0197 Evaluation of a dosing regimen for tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis

المؤلفون: Rik Joos, Joy C. Hsu, Navita L. Mallalieu, Ruben Cuttica, Sunethra Wimalasundera, Kenneth N. Schikler, D. Milojevic, K Wang, Hans Iko Huppertz, Margalit Rosenkranz, Chris Wells, Carine Wouters, I. Calvo Penadés, Yukiko Kimura, Tamás Constantin

المصدر: Oral Presentations.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7ee319aff1865e1441d223d747f33a6f
https://doi.org/10.1136/annrheumdis-2017-eular.2386

تنقيح النتائج